Filing Details

Accession Number:
0001209191-14-032368
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-08 17:57:47
Reporting Period:
2014-05-07
Filing Date:
2014-05-08
Accepted Time:
2014-05-08 17:57:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1341235 Aldeyra Therapeutics Inc. ALDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579179 C Todd Brady C/O Aldeyra Therapeutics, Inc.
15 New England Executive Park
Burlington MA 01803
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-07 12,500 $8.00 15,089 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2014-05-07 76,068 $0.00 76,068 $8.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
76,068 2024-05-06 No 4 A Direct
Footnotes
  1. Exercisable in equal annual installments over three years of continuous service after May 7, 2014.